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Background: The relative validity of food frequency questionnaires for estimating long-chain poly-
unsaturated fatty acid (LC-PUFA) intake among pregnant Japanese women is currently unclear. The aim
of this study was to verify the external validity of a food frequency questionnaire, originally developed
for non-pregnant adults, to assess the dietary intake of LC-PUFA using dietary records and serum
phospholipid levels among Japanese women in early and late pregnancy.
Methods: A validation study involving 188 participants in early pregnancy and 169 participants in late
pregnancy was conducted. Intake LC-PUFA was estimated using a food frequency questionnaire and
evaluated using a 3-day dietary record and serum phospholipid concentrations in both early and late
pregnancy.
Results: The food frequency questionnaire provided estimates of eicosapentaenoic acid (EPA) and do-
cosahexaenoic acid (DHA) intake with higher precision than dietary records in both early and late
pregnancy. Signiﬁcant correlations were observed for LC-PUFA intake estimated using dietary records in
both early and late pregnancy, particularly for EPA and DHA (correlation coefﬁcients ranged from 0.34 to
0.40, p < 0.0001). Similarly, high correlations for EPA and DHA in serum phospholipid composition were
also observed in both early and late pregnancy (correlation coefﬁcients ranged 0.27 to 0.34, p < 0.0001).
Conclusions: Our ﬁndings suggest that the food frequency questionnaire, which was originally designed
for non-pregnant adults and was evaluated in this study against dietary records and biological markers,
has good validity for assessing LC-PUFA intake, especially EPA and DHA intake, among Japanese women
in early and late pregnancy.
© 2016 The Authors. Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Essential fatty acids, especially their long-chain polyunsaturated
derivatives, are primary structural components of cell membranes.
Increasing evidence suggests that long-chain polyunsaturated fatty
acids (LC-PUFAs) may be important in fetal development and thelth Promotion, Tokyo Medical
okyo, 113-8519, Japan.
ra).
demiological Association.
Elsevier B.V. on behalf of The Japa
d/4.0/).accretion of maternal, placental, and fetal tissue.1e4 In particular, n-
3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA), comprise the major structural fat
of the human brain and eyes.5e7 The Japanese diet is rich in n-3
PUFAs due to a high consumption of seafood, and the epidemio-
logical beneﬁts of these fatty acids have been widely reported.8e11
Food frequency questionnaires (FFQs) are useful for assessing
dietary habits and quantitatively estimating usual food consump-
tion over a ﬁxed period of time. However, like all dietary methods,
estimated nutrients derived from FFQs suffer from random and
systematic error and may not accurately reﬂect usual food intake.12n Epidemiological Association. This is an open access article under the CC BY-NC-ND
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mation may give rise to misleading associations between dietary
factors and diseases.
The relative validity of the FFQ for assessing LC-PUFA intake in
Japan has been previously reported.13,14 However, a validation
study of the FFQ for pregnant women is required, as pregnant
women are likely to experience a change in dietary habits as well as
appetite or to choose food that is different than their pre-pregnancy
diet, which consequently changes their everyday dietary intake.15,16
Although plurality of dietary records (DR) is the most frequent
reference method to validate FFQs, biomarkers that show a strong
direct relationship with the nutrient of interest may also be used as
a reference to validate the FFQ, as their measurement errors would
be independent from those of dietary assessment methods.17,18 For
dietary EPA and DHA intake measured by FFQs, several previous
studies have used EPA and DHA concentrations in the blood for
validation.19,20
The aim of this study was to verify the external validity of an
FFQ, which was originally developed for non-pregnant adults, to
assess the dietary intake of LC-PUFAs using the dietary records and
biomarkers of LC-PUFAs in serum phospholipid levels among
women in early and late pregnancy.
2. Methods
2.1. Participants
A validation study of a FFQ was performed to estimate the di-
etary intake of LC-PUFAs in a selected subset of pregnant women
conducted at the National Center for Child Health and Development
(NCCHD) in Tokyo, Japan. Participants were enrolled at 5e15 weeks
of gestation. Of the 248 women initially enrolled in the validation
study, 60 were excluded in early pregnancy for the following rea-
sons: withdrawal from the study (n ¼ 21), inability to eat due to
hyperemesis gravidarum (n ¼ 2), missing FFQ data (n ¼ 21), and
incomplete dietary records (n ¼ 16). Ultimately, 188 early-
pregnancy participants completed both the 3-day dietary records
and the FFQ at 5e15 weeks of gestation. Of these participants, 186
had a blood sample taken before the FFQ at 8e14 weeks of gesta-
tion. Of the 248 women initially enrolled, 79 womenwere excluded
in late pregnancy for the following reasons: withdrawal from the
study (n ¼ 21), inability to eat due to hyperemesis gravidarum
(n ¼ 2), missing FFQ data (n ¼ 50), and incomplete dietary records
(n¼ 6). Ultimately,169 late-pregnancy participants completed both
the 3-day dietary records and the FFQ during late pregnancy at
26e35 weeks of gestation. Of these participants, 153 had a blood
sample taken before the FFQ at 20e30 weeks of gestation. There
were no substantial differences in baseline characteristics between
the enrolled participants and the included participants (all p > 0.2).
2.2. Standard protocol approvals, registrations, and patient consent
Written informed consent was obtained from all participants at
enrollment, and the Institutional Review Board at the NCCHD
approved this study (Approval No. 467). The present study was
conducted according to the guidelines of theDeclaration of Helsinki.
2.3. Food frequency questionnaire (FFQ)
The FFQ included 167 food and beverage items. Respondents
were asked to indicate their usual consumption for each item
within the past 2 months using nine frequency categories, starting
from almost never to seven or more times per day (or, for bever-
ages, to 10 glasses per day). We modiﬁed the original version of the
food list used in the Japan Public Health Center-based ProspectiveStudy21 by adding six foods and a beverage consumed in urban
areas: ground meat, pastry, corn ﬂakes, pudding, jelly, and cock-
tails. The list also included 20 items rich in n-3 PUFA, such as ﬁsh,
shellﬁsh, and other ﬁsh products. For each food and item, portion
size was indicated by three standard sizes: small (50% smaller than
usual), medium (the standard amount), and large (50% larger than
usual). Energy and LC-PUFA intakes were calculated using a food
composition table developed for the FFQ based on the Standardized
Tables of Food Composition in Japan (2010 edition).22
2.4. Dietary records
Participants noted their food and beverage consumption in di-
etary records for 3 days in early pregnancy between 5 and 15 weeks
of gestation, and for 3 days in late pregnancy between 26 and 35
weeks of gestation, before completion of the FFQ and following the
protocol of the original validation study.23 These records docu-
mented women's dietary intake over 2 weekdays and 1 weekend
day, and were used as the reference method for this study. For each
meal during these 3 days, participants were asked to measure all
food portions using digital scales, measuring spoons, and cups and
document all ingredients and preparation methods. Trained di-
etitians would then telephone each participant and verify the re-
cord, as well as code the foods and the amounts prepared. Energy
and LC-PUFA intakes were calculated using the Standard Tables of
Food Composition in Japan (2010 edition).22
2.5. Serum phospholipid levels
Non-fasting blood samples were obtained from each participant
at enrollment and late pregnancy between 26 and 35 weeks of
gestation. Blood samples were separated by centrifugation for
5 min at 3,000 rpm immediately after venipuncture and stored
at 40 C in the NCCHD's hospital laboratory. Samples were then
packed with dry ice and carefully transported to an external labo-
ratory for analysis (SRL. Inc., Hachioji, Tokyo, Japan). Serum phos-
pholipids were extracted using chloroform-methanol (2:1 v/v)
followed by acid hydrolysis. After being esteriﬁed in boron
triﬂuoride-methanol, serum fatty acid composition was analyzed
by gas chromatography using a Shimadzu model GC-2010 gas
chromatograph (Shimadzu, Kyoto, Japan) equipped with column
capillary polyethylene glycol Omegawax (30 m in length, 0.25 mm
internal diameter, 0.25 mm ﬁlm thickness,; Sigma-Aldrich Co. LLC,
St. Louis, MO, USA). Concentrations of each fatty acid were
expressed as a proportion of all serum fatty acids.
2.6. Statistical analysis
Paired t-tests were used to test the difference between FFQ and
dietary record estimates of LC-PUFA intake for both early and late
pregnancy. Spearman correlation coefﬁcients were calculated be-
tween the FFQ and dietary record estimates or responsive LC-PUFA
levels of serum phospholipids. The degree of misclassiﬁcation
across categories was examined between FFQ and dietary records
or between FFQ and serum phospholipid levels by dividing LC-
PUFA intake estimated from the FFQ into quintiles. Mean dietary
record values or LC-PUFA composition in serum phospholipids
were calculated and assigned to categories deﬁned using the di-
etary records or serum phospholipid levels. An analysis of variance
with a Tukey-Kramer post-hoc comparison of means was per-
formed to test for differences between the lowest and highest
quintiles. Trend tests were conducted by median for each category
of intake. Statistical analyses were performed using SAS statistical
software (version 9.4; SAS Institute Inc, Cary, NC, USA).
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The mean (standard deviation [SD]) age of participants was 36.6
(3.9) years, and 64.9% of participants were primipara. Of all par-
ticipants, 64.7% were college educated or more, and 60.9% had an
annual household income over 8 million yen. A large proportion of
participants (78.6%) reported feeling nauseous during early preg-
nancy. Dietary records estimated the mean (SD) total energy intake
during early and late pregnancy as 1,643 (403) kcal and 1,792 (337)
kcal, respectively. Supplemental use of folic acid during early and
late pregnancy was reported by 73.9% and 45.8% of participants,
respectively. Only 1.6% and 4.7% of participants used n-3 PUFA
supplementation at early and late pregnancy, respectively (Table 1).
The FFQ overestimated the intake of a-linolenic acid compared
with the dietary records in both early and late pregnancy. In
contrast, the FFQ underestimated the intake of arachidonic acid in
early and late pregnancy, as well as EPA and DHA intake in early
pregnancy, when intake was denoted as the percentage of total
fatty acids. The mean intake of EPA and DHA were not signiﬁcantly
different between the FFQ and dietary recordswhenmeasured as g/
day (Table 2).
The Spearman correlation coefﬁcients between the FFQ and
dietary records of each LC-PUFA crude intake were statisticallyTable 1
Characteristics of participants.
Characteristics
Number of weeks pregnant when ﬁlling in the FFQ (mean (range))
Maternal age, years (mean (SD))
Dietary intake estimated from DR (mean (SD))
Total energy, kcal/day
Total fatty acid, g/day
SFA, g/day
MUFA, g/day
PUFA, g/day
Dietary intake estimated from FFQ (mean (SD))
Total energy, kcal/day
Total fatty acid, g/day
SFA, g/day
MUFA, g/day
PUFA, g/day
Serum phospholipid level, %
EPA (20:5n-3)
DHA (22:6n-3)
Nausea at time of ﬁlling in the FFQ (n, (%))
Parity (n, (%))
0
1
Education (n, (%))
Less than high school or high school diploma
Some college
College graduate or post-graduate
Household income (n, (%))
<4 million yen
4e8 million yen
>8 million yen
BMI prior to pregnancy (n, (%))
<18.5
18.5e25.0
25.0
Smoking status in pregnancy (n, (%))
Current
Alcohol intake in pregnancy (n, (%))
>once/week
Dietary supplement use at time of ﬁlling in the FFQ (n, (%))
Folic acid
Zinc
Long-chain n-3 fatty acids
BMI, body mass index; DHA, docosapentaenoic acids; DR, dietary records; EPA, eicosape
acids; PUFA, poly unsaturated fatty acids; SFA, saturated fatty acids.
Data are presented as mean (range), mean (standard deviation), or number (%).signiﬁcant in both early and late pregnancy. Correlation coefﬁcients
were reduced when LC-PUFAs were denoted as the percentage of
total fatty acids; however, EPA and DHA still had high correlation
coefﬁcients (r > 0.3). The Spearman correlation coefﬁcients be-
tween LC-PUFA intake from the FFQ and LC-PUFAs in serum
phospholipid levels were statistically signiﬁcant in early pregnancy,
when LC-PUFAs were denoted as the percentage of total fatty acids.
However, at late pregnancy, the correlation coefﬁcients were weak
except for EPA and DHA (both r > 0.3) (Table 3).
Quintiles of LC-PUFA intake estimated from dietary records
tended to rise with the quintile of increasing LC-PUFA intake esti-
mated from the FFQ, except for a-linolenic acid in both early and
late pregnancy. The lowest versus the highest LC-PUFA intake were
signiﬁcantly different for total n-3 PUFA, DHA, total n-6 PUFA, and
linoleic acid in early pregnancy, and for EPA, total n-6 PUFA, and
arachidonic acid in late pregnancy (Table 4).
Quintiles of both n-3 PUFA and n-6 PUFA composition of serum
phospholipid levels tended to rise with the quintile of increasing
LC-PUFA intake estimated from the FFQ at early pregnancy. How-
ever, at late pregnancy, the quintiles of n-6 PUFA composition of
serum phospholipid levels did not show any marked differences in
the trend. The lowest versus the highest LC-PUFA composition of
serum phospholipid were signiﬁcantly different, except forEarly pregnancy (n ¼ 188) Late pregnancy (n ¼ 169)
10.2 (5e15) 29.2 (26e35)
36.6 (3.9)
1643 (403) 1792 (337)
46.4 (17.2) 55.0 (16.0)
16.5 (6.7) 20.3 (6.8)
19.4 (7.9) 22.9 (7.3)
10.4 -(4.1) 11.7 (3.5)
1744 (560) 1784 (600)
49.0 (21.1) 55.6 (25.2)
18.2 (9.2) 21.7 (12.4)
19.3 (8.4) 21.7 (9.5)
11.5 (4.9) 12.1 (4.7)
1.0 (0.6) 0.9 (0.7)
4.6 (0.9) 4.3 (1.0)
92 (78.6) 8 (8.7)
122 (64.9)
66 (35.1)
13 (7.0)
53 (28.3)
121 (64.7)
12 (6.5)
60 (32.6)
112 (60.9)
42 (22.3)
137 (72.9)
9 (4.8)
1 (0.5) 0 (0.0)
9 (4.8) 5 (3.0)
139 (73.9) 71 (45.8)
12 (6.4) 15 (9.7)
3 (1.6) 8 (4.7)
ntaenoic acids; FFQ, food frequency questionnaire; MUFA, mono unsaturated fatty
Table 2
Long-chain fatty acid intake estimated by FFQ and dietary records, and % difference of intake at early pregnancy and late pregnancy.
Early pregnancy (n ¼ 188) Late pregnancy (n ¼ 169)
FFQ DR p valuea % differenceb FFQ DR p valuea % differenceb
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
(g/day)
n-3 PUFA 1.79 (0.79) 1.58 (0.75) 0.002 12 1.97 (0.84) 1.78 (0.77) 0.016 10
a-linolenic acid 1.34 (0.60) 1.10 (0.51) <0.0001 18 1.41 (0.58) 1.19 (0.42) <0.0001 15
EPA 0.13 (0.10) 0.14 (0.15) 0.695 3 0.16 (0.12) 0.16 (0.18) 0.825 2
DHA 0.23 (0.16) 0.25 (0.24) 0.344 7 0.28 (0.20) 0.31 (0.29) 0.292 9
n-6 PUFA 9.64 (4.12) 8.84 (3.49) 0.022 8 10.13 (3.95) 9.89 (3.03) 0.447 2
Linoleic acid 9.44 (4.05) 8.61 (3.43) 0.016 9 9.90 (3.88) 9.61 (2.99) 0.360 3
Arachidonic acid 0.12 (0.06) 0.12 (0.06) 0.436 3 0.13 (0.06) 0.14 (0.05) 0.027 8
(% of TFA)
n-3 PUFA 3.71 (0.96) 3.49 (1.45) 0.042 6 3.67 (0.94) 3.32 (1.24) 0.002 10
a-linolenic acid 2.78 (0.69) 2.40 (0.75) <0.0001 14 2.63 (0.59) 2.22 (0.66) <0.0001 16
EPA 0.27 (0.19) 0.32 (0.41) 0.112 18 0.30 (0.21) 0.29 (0.30) 0.755 3
DHA 0.48 (0.29) 0.57 (0.61) 0.057 18 0.53 (0.33) 0.58 (0.52) 0.235 9
n-6 PUFA 20.00 (3.97) 19.26 (4.35) 0.048 4 18.92 (3.76) 18.30 (3.69) 0.078 3
Linoleic acid 19.60 (4.03) 18.76 (4.36) 0.027 4 18.51 (3.81) 17.79 (3.71) 0.044 4
Arachidonic acid 0.24 (0.07) 0.26 (0.10) 0.004 10 0.24 (0.06) 0.27 (0.10) 0.001 12
DHA, docosahexaenoic acids; DR, dietary record; EPA, eicosapentaenoic acids; FFQ, food frequency questionnaire; n-3 PUFA, n-3 polyunsaturated fatty acids; n-6 PUFA, n-6
polyunsaturated fatty acids.
a Paired t-test.
b (mean of FFQ e mean of DR)/mean of DR (%).
Table 3
Spearman correlation coefﬁcient between dietary fatty acid intake estimated by FFQ
and dietary records and corresponding fatty acids by composition of serum PL at
early and late pregnancy.
FFQ and DR FFQ and serum PL
g/day % of TFA mg/ml % of TFA
Early pregnancy (n ¼ 188) (n ¼ 186)
n-3 PUFA 0.33 *** 0.35 *** 0.13 0.29 ***
a-linolenic acid 0.18 * 0.11 0.13 0.22 **
EPA 0.38 *** 0.33 *** 0.37 *** 0.45 ***
DHA 0.40 *** 0.32 *** 0.27 ** 0.35 ***
n-6 PUFA 0.24 ** 0.21 ** 0.04 0.23 **
Linoleic acid 0.23 ** 0.21 ** 0.07 0.26 **
Arachidonic acid 0.33 *** 0.21 ** 0.02 0.18 *
Late pregnancy (n ¼ 169) (n ¼ 153)
n-3 PUFA 0.32 *** 0.18 * 0.15 0.30 **
a-linolenic acid 0.32 *** 0.08 0.05 0.10
EPA 0.37 *** 0.32 *** 0.33 *** 0.33 ***
DHA 0.34 *** 0.30 *** 0.28 ** 0.34 ***
n-6 PUFA 0.35 *** 0.25 ** 0.03 0.02
Linoleic acid 0.35 *** 0.25 ** 0.02 0.00
Arachidonic acid 0.29 ** 0.21 ** 0.08 0.13
DHA, docosahexaenoic acids; DR, dietary records; EPA, eicosapentaenoic acids; FFQ,
food frequency questionnaire; n-3 PUFA, n-3 polyunsaturated fatty acids; n-6 PUFA,
n-6 polyunsaturated fatty acids; PL, phospholipids; TFA, total fatty acids.
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highest LC-PUFA composition of serum phospholipid were only
signiﬁcantly different for EPA and DHA at late pregnancy (Table 5).4. Discussion
This study demonstrated that the FFQ estimates of LC-PUFA
intake showed signiﬁcant correlations with estimates using di-
etary records as a reference, with particularly high correlations for
EPA and DHA. High correlations were also observed between the
EPA and DHA intake estimated by the FFQ and the corresponding
fatty acids of serum phospholipid levels.
The most frequently used biomarkers for intake of EPA and DHA
are adipose tissue, plasma, serum, or erythrocytes phospholipid
levels.19,20 In our study, observed correlation coefﬁcients betweennutrients and serum levels (r¼ 0.37 for EPA and 0.27 for DHA) were
superior to another study that compared similar correlations in
pregnant Japanesewomen24 (r¼ 0.34 for EPA and 0.16 for DHA) and
were similar to a report comparing erythrocyte phospholipid levels
and dietary intake in pregnant Mexican women (r ¼ 0.36 for EPA
and 0.35 for DHA),25 as well as another report comparing eryth-
rocyte EPA levels and total n-3 PUFA intake in pregnant Danish
women (r ¼ 0.37).26 Very few studies have compared n-3 PUFA,
EPA, and DHA intake estimated from dietary records or recall. A
previous study in Brazil showed correlations (r ¼ 0.09 for EPA
and 0.0001 for DHA)27 lower than our study (r ¼ 0.38 and
r ¼ 0.40, respectively).
One reason our study showed fairly good correlations is prob-
ably due to the fact that our population included women who
frequently consumed seafood, leading to a large variation in its
consumption. Currently, there are no concrete recommendations
for EPA and DHA in Japan during pregnancy due to the conﬂicting
issues of concerns about the adverse health effects of prenatal
methylmercury exposure from ﬁsh and the known beneﬁts of
adequate n-3 PUFA intake.28 However, our study population
showed higher seafood consumption than the average Japanese
woman of similar age (0.06 g/day of EPA and 0.16 g/day of DHA).29
Our previous validation of the same FFQ in middle-aged Japanese
womenwho had higher seafood consumption (0.4 g/day of EPA and
0.7 g/day of DHA) showed similar and even superior correlations
(r ¼ 0.59 for EPA and 0.49 for DHA).13
Another reason for the high correlations could be due to our FFQ
covering a wide range of seafood, thus reducing measurement er-
ror, as our correlations were superior to a previous study in preg-
nant Japanese women with a similar average intake of EPA and
DHA.23 On the other hand, our study showed poor correlations for
a-linolenic acid, linoleic acid, and arachidonic acid intake. A large
proportion of the intake of these acids is from cooking oil, which
our FFQ may be limited in accurately measuring.
BMI, smoking status, and alcohol consumption have been re-
ported to inﬂuence serum or plasma LC-n3 PUFA levels.30e32 Most
participants in our sample were non-smokers and did not consume
alcohol. Observed validity did not vary among the 73% of partici-
pants with a healthy BMI in the range of 18.5e25.0. It has been
reported that LC-n3 PUFA supplementation is likely to be a strong
Table 4
Fatty acid intake estimated by dietary records according to quintiles deﬁned by fatty acid intake estimated by FFQ at early and late pregnancy.
Fatty acids intake (% of TFA) Level in quintiles on the basis of fatty acid intake estimated by FFQ (mean (SD)) Q1 vs Q5a P For trend
Q1 Q2 Q3 Q4 Q5
Early pregnancy (n ¼ 37) (n ¼ 38) (n ¼ 38) (n ¼ 38) (n ¼ 37)
n-3 PUFA 3.14 (1.27) 2.90 (1.00) 3.60 (1.78) 3.57 (1.18) 4.28 (1.55) 0.004 <0.0001
a-linolenic acid 2.26 (0.78) 2.46 (0.84) 2.24 (0.73) 2.44 (0.74) 2.58 (0.62) 0.374 0.116
EPA 0.21 (0.39) 0.24 (0.35) 0.38 (0.57) 0.33 (0.28) 0.45 (0.36) 0.094 0.008
DHA 0.34 (0.39) 0.54 (0.71) 0.64 (0.78) 0.56 (0.43) 0.77 (0.59) 0.019 0.005
n-6 PUFA 18.09 (3.96) 19.11 (4.70) 18.11 (4.34) 19.77 (3.74) 21.23 (4.38) 0.015 0.002
Linoleic acid 17.45 (4.09) 18.76 (4.58) 17.66 (4.42) 19.22 (3.64) 20.71 (4.44) 0.010 0.002
Arachidonic acid 0.26 (0.10) 0.25 (0.10) 0.24 (0.09) 0.27 (0.10) 0.30 (0.08) 0.338 0.040
Late pregnancy (n ¼ 33) (n ¼ 34) (n ¼ 34) (n ¼ 34) (n ¼ 34)
n-3 PUFA 3.17 (1.43) 3.13 (1.17) 3.16 (1.16) 3.54 (1.13) 3.58 (1.26) 0.647 0.068
a-linolenic acid 2.13 (0.70) 2.27 (0.83) 2.30 (0.65) 2.08 (0.53) 2.31 (0.55) 0.790 0.631
EPA 0.16 (0.18) 0.26 (0.33) 0.30 (0.29) 0.33 (0.25) 0.41 (0.38) 0.008 0.001
DHA 0.41 (0.44) 0.49 (0.47) 0.60 (0.50) 0.65 (0.51) 0.75 (0.61) 0.055 0.003
n-6 PUFA 16.40 (3.43) 18.59 (3.71) 17.73 (2.34) 18.73 (3.95) 20.00 (3.97) 0.001 <0.001
Linoleic acid 15.92 (3.46) 18.02 (3.78) 17.37 (2.24) 18.34 (4.01) 19.24 (4.09) 0.002 0.001
Arachidonic acid 0.27 (0.09) 0.24 (0.07) 0.28 (0.13) 0.27 (0.09) 0.31 (0.08) 0.263 0.014
DHA, docosahexaenoic acids; DR, dietary records; EPA, eicosapentaenoic acids; FFQ, food frequency questionnaire; n-3 PUFA, n-3 polyunsaturated fatty acids; n-6 PUFA, n-6
polyunsaturated fatty acids; TFA, total fatty acids.
a Tukey-Kramer analysis.
Table 5
Fatty acid composition of serum PL according to quintiles deﬁned by fatty acid intake estimated by FFQ at early and late pregnancy.
Fatty acids intake (% of TFA) Level in quintiles on the basis of fatty acid intake estimated by FFQ (mean (SD) Q1 vs Q5a P for trend
Q1 Q2 Q3 Q4 Q5
Early pregnancy (n ¼ 37) (n ¼ 37) (n ¼ 38) (n ¼ 37) (n ¼ 37)
n-3 PUFA 5.94 (1.22) 6.07 (0.95) 6.45 (1.37) 6.36 (1.30) 7.19 (1.73) 0.001 <0.0001
a-linolenic acid 0.68 (0.21) 0.73 (0.19) 0.77 (0.29) 0.78 (0.24) 0.84 (0.28) 0.055 0.005
EPA 0.71 (0.45) 0.86 (0.47) 0.88 (0.50) 1.10 (0.75) 1.45 (0.72) <0.0001 <0.0001
DHA 4.14 (0.81) 4.26 (0.74) 4.76 (0.80) 4.47 (0.78) 5.26 (1.00) <0.0001 <0.0001
n-6 PUFA 37.09 (2.66) 37.67 (3.11) 38.53 (2.99) 37.99 (2.53) 39.06 (2.83) 0.026 0.004
Linoleic acid 27.25 (3.03) 28.29 (2.87) 28.99 (3.33) 28.35 (2.57) 29.49 (3.00) 0.012 0.004
Arachidonic acid 6.55 (1.23) 6.93 (1.33) 6.78 (1.14) 7.02 (1.26) 7.19 (1.32) 0.195 0.039
Late pregnancy (n ¼ 30) (n ¼ 31) (n ¼ 31) (n ¼ 31) (n ¼ 30)
n-3 PUFA 5.68 (1.40) 5.78 (1.73) 6.33 (1.13) 6.17 (1.51) 7.02 (1.59) 0.006 <0.001
a-linolenic acid 0.86 (0.17) 0.89 (0.25) 0.84 (0.14) 0.89 (0.24) 0.95 (0.23) 0.538 0.192
EPA 0.69 (0.41) 0.73 (0.37) 0.86 (0.48) 1.14 (0.78) 1.22 (0.92) 0.012 <0.0001
DHA 3.92 (0.88) 3.90 (0.81) 4.40 (1.02) 4.73 (1.18) 4.63 (1.01) 0.044 <0.001
n-6 PUFA 37.05 (2.90) 34.68 (4.23) 36.46 (2.99) 36.25 (2.91) 35.93 (2.71) 0.655 0.718
Linoleic acid 28.72 (3.10) 26.88 (3.59) 28.65 (2.74) 28.23 (2.98) 27.75 (2.94) 0.741 0.737
Arachidonic acid 5.11 (0.81) 5.60 (1.06) 5.39 (1.02) 5.77 (0.95) 5.43 (1.09) 0.709 0.150
FFQ, food frequency questionnaire; n-3 PUFA, n-3 polyunsaturated fatty acids; n-6 PUFA, n-6 polyunsaturated fatty acids; PL, phospholipids; TFA, total fatty acids.
a Tukey-Kramer analysis.
M. Kobayashi et al. / Journal of Epidemiology 27 (2017) 30e3534contributor to the correlation between LC-n3 PUFA intake and
serum level.33e35 As only a few participants in our study used LC-n3
PUFA supplements, it is likely that supplementation did not affect
validity.
Maternal food choice and dietary habits can change consider-
ably within a short period due to emesis gravidarum.36 We
excluded from our analysis two participants with serious symp-
toms of emesis; however, changes to dietary habits due to morning
sickness were not taken into account for the remaining partici-
pants. Food and nutrient intake estimated from the FFQ in this
study was previously validated, regardless of morning sickness
symptoms (in press, Ogawa, et al.).
We found that, for EPA and DHA, our FFQ categorized subjects
into quintiles that showed a signiﬁcant trend not only in intake
calculated from DR but also composition in serum phospholipids.
The estimated intake of EPA and DHA from the FFQ and DRwere not
signiﬁcantly different, and the percentage difference in the mean
intake between the two methods was within 20% to þ20% for
both early and late pregnancy, so EPA and DHA intakes were likelynot over- or under-estimated in the FFQ. Therefore, we think it is
possible to rank participants according to intake and to estimate
their absolute intake using this FFQ.
Although we validated our FFQ using both DR and biomarkers in
the present study, correlations between DR and serum levels were
not superior to those between the FFQ and serum levels (data not
shown), contrary to the ﬁndings of the original study.13 This may be
because the DR and blood collection were not consecutive but
several weeks apart, so serum levels correlated better with the FFQ,
whichmeasures food intake over a broader time period, rather than
DR, which measures food intake over 3 days.
In drawing conclusions from the present study, certain limita-
tions of the study design should be considered. First, food selection
in our study sample may have been biased, since the research was
conducted in Setagaya, an afﬂuent area of Tokyo where participants
were relatively wealthy and older. Having a higher educational
background, higher household income, and older maternal agemay
have inﬂuenced some participants' dietary habits. Second, as di-
etary habits can change considerably within a short period during
M. Kobayashi et al. / Journal of Epidemiology 27 (2017) 30e35 35pregnancy,36 the reported correlations may lead to measurement
error. Finally, the investigation times for early and late pregnancy
varied between participants, and seasonal variation of food con-
sumption was not considered.
In summary, our ﬁndings suggest that the FFQ, originally
developed for non-pregnant adults, has acceptable validity for
assessing LC-PUFA intake in pregnant Japanese women compared
to DR and biological markers, especially for EPA and DHA intake.
We conclude that our FFQ is a suitable tool for assessing LC-PUFA
intake, particularly EPA and DHA intake, during pregnancy.
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